Neural retinal impairment linked to flicker light response

Article

The impairment of vascular response to flicker lights could reveal inner retinal neural impairment in patients with diabetic retinopathy (DR)

The impairment of vascular response to flicker lights could reveal inner retinal neural impairment in patients with diabetic retinopathy (DR), according to a study published in Investigative Ophthalmology and Visual Science.

Dr Pascale Massin et al., Department of Ophthalmology, Lariboisière Hospital, Paris, France, studied 28 normotensive, diabetic patients wihout DR and 28 healthy patients of the same age and sex as the control group. All patients underwent colour vision and contrast sensitivity tests, evaluation of the vascular reponse to flicker lights with the dynamic vessel analyser (DVA) and pattern, full field and multifocal electroretinogram (ERG).

It was found that diabetic patients experienced significantly impaired ERG pattern responses in comparison with the healthy subjects. This included the b-wave in the scotopic bright flash ERG, the a-wave and b-wave in the photopic single flash ERG. The vascular response to flicker light in diabetic patients compared to the control group was impaired.

Correlations were discovered between flicker light-induced arterial retinal vasodilation and the amplitude and implied times of the N95 wave of pattern ERG throughout the whole study group.

No strong correlation was found between the result of the diabetic patients, but it was concluded that neural and neovascular dysfunctions come before the start of clinically detectable DR.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.